id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
NRC-2022-0218-0195,NRC,NRC-2022-0218,"LTR-24-0219 Dana Smetherman, Chief Executive Officer, American College of Radiology, Letter re: SECY-24-0067 on Proposed Rule - Reporting Nuclear Medicine Injection Extravasation as Medical Events",Supporting & Related Material,,2025-02-11T00:00:00Z,2025,2,,,2025-05-21T06:20:58Z,,0,0,090000648694f2b4
NRC-2022-0218-0196,NRC,NRC-2022-0218,10-16-24 Letter from Simon Davies to NRC,Supporting & Related Material,,2025-02-11T00:00:00Z,2025,2,,,2025-05-21T06:20:57Z,,0,0,090000648694f2b5
NRC-2022-0218-0199,NRC,NRC-2022-0218,10-21-24 DG-8062 Public Comment From YSC,Supporting & Related Material,,2025-02-11T00:00:00Z,2025,2,,,2025-05-21T06:20:58Z,,0,0,090000648694f2b8
NRC-2022-0218-0197,NRC,NRC-2022-0218,"LTR-24-0227 Simon Davies, Executive Director, Teen Cancer America, Patients for Safer Nuclear Medicine Spokesperson, comments on Nuclear Regulatory Commission's Draft Regulatory Guide DG-8062 for radiopharmaceutical extravasation reporting",Supporting & Related Material,,2025-02-11T00:00:00Z,2025,2,,,2025-05-21T06:20:58Z,,0,0,090000648694f2b6
NRC-2022-0218-0198,NRC,NRC-2022-0218,Venus Gines Commenting on Draft Regulatory Guide,Supporting & Related Material,,2025-02-11T00:00:00Z,2025,2,,,2025-05-21T06:20:58Z,,0,0,090000648694f2b7
NRC-2022-0218-0190,NRC,NRC-2022-0218,"07-10-24 Ron Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request submitted to NRC in February 2023, and the most recent NRC OIG findings",Supporting & Related Material,,2024-09-30T00:00:00Z,2024,9,,,2025-05-21T06:22:01Z,,0,0,09000064867a2e8b
NRC-2022-0218-0191,NRC,NRC-2022-0218,"08-27-24 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: NRC's reply and the proposed rule regarding the reporting of extravasations",Supporting & Related Material,,2024-09-30T00:00:00Z,2024,9,,,2025-05-21T06:22:01Z,,0,0,09000064867a2e8d
NRC-2022-0218-0189,NRC,NRC-2022-0218,"April 11, 2023 - NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter regarding Extravasation, Abnormal Occurrence reporting, and Information Correction Requests",Supporting & Related Material,,2024-09-25T00:00:00Z,2024,9,,,2025-05-21T06:22:02Z,,0,0,0900006486786688
NRC-2022-0218-0188,NRC,NRC-2022-0218,"June 28, 2023 - Response to Ronald Lattanze Appeal Letter to the NRC Information Quality Coordinator dated May 12, 2023 re: SECY-22-0043, “Petition for Rulemaking and Rulemaking Plan on Reporting Nuclear Medicine Injection Extravasations as Medical Events""",Supporting & Related Material,,2024-09-25T00:00:00Z,2024,9,,,2025-05-21T06:22:02Z,,0,0,09000064867846bb
NRC-2022-0218-0187,NRC,NRC-2022-0218,"August 8, 2024 - NRC Response to R. Lattanze July 2024 Letter",Supporting & Related Material,,2024-09-25T00:00:00Z,2024,9,,,2025-05-21T06:22:02Z,,0,0,09000064867846b9
NRC-2022-0218-0185,NRC,NRC-2022-0218,"August 7, 2024 - Letter to NRC medical staff re proposed rule and 99mTC case report",Supporting & Related Material,,2024-08-25T00:00:00Z,2024,8,,,2025-05-21T06:24:12Z,,0,0,090000648667632d
NRC-2022-0218-0184,NRC,NRC-2022-0218,"April 4, 2023 - LTR-23-0081 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request Follow-up",Supporting & Related Material,,2024-08-25T00:00:00Z,2024,8,,,2025-05-21T06:24:12Z,,0,0,0900006486672f5e
NRC-2022-0218-0186,NRC,NRC-2022-0218,"July 1, 2024 Email to Raymond Furstenau from Teen Cancer America and K. Williams Response Regarding Extravasations rulemaking",Supporting & Related Material,,2024-08-25T00:00:00Z,2024,8,,,2025-05-21T06:24:12Z,,0,0,090000648667632e
NRC-2022-0218-0182,NRC,NRC-2022-0218,"June 15, 2023 - LTR-23-0157 - Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, Letter re: Extravasations, Abnormal Occurrence reporting, and Information Correction Request",Supporting & Related Material,,2024-08-23T00:00:00Z,2024,8,,,2025-05-21T06:24:12Z,,0,0,0900006486672ea7
NRC-2022-0218-0183,NRC,NRC-2022-0218,"February 15, 2024 - LTR-24-0030 Mary Ajango, Spokesperson, Patients for Safer Nuclear Medicine Coalition, Letter re: concerns about reporting requirements for extravasations
ML24051A042",Supporting & Related Material,,2024-08-23T00:00:00Z,2024,8,,,2025-05-21T06:24:12Z,,0,0,0900006486674c6a
NRC-2022-0218-0173,NRC,NRC-2022-0218,Draft for ACMUI Review - Draft Model Procedures for Evaluating and Reporting Extravasation Medical Events,Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,090000648665e6b5
NRC-2022-0218-0176,NRC,NRC-2022-0218,"June 11, 2024 - Draft Report - Subcommittee on Extravasations",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,090000648665e6f3
NRC-2022-0218-0180,NRC,NRC-2022-0218,"February 16, 2023 - LTR-23-0038 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Extravasation, Abnormal Occurrence Reporting, and Information Correction Requests",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,1,090000648665e7ce
NRC-2022-0218-0174,NRC,NRC-2022-0218,"June 17, 2024 - MUI Extravasations Meeting Handout",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,090000648665e6b8
NRC-2022-0218-0175,NRC,NRC-2022-0218,"August 21, 2024 - For ACMUI Review - Preliminary Extravasation Proposed Rule Package",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,090000648665e6bb
NRC-2022-0218-0178,NRC,NRC-2022-0218,"June 17, 2024 - Transcript of Meeting of the Advisory Committee on the Medical Uses of Isotopes - Pages 1 - 93",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,090000648665ec26
NRC-2022-0218-0181,NRC,NRC-2022-0218,"May 12, 2023  LTR-23-0129 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re:  Abnormal Occurrence Reporting, and Information Correction Request",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,09000064866601ee
NRC-2022-0218-0179,NRC,NRC-2022-0218,"NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC - Letter regarding Extravasation. Abnormal Occurrence Reporting and Information Correction Requests",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,090000648665ed18
NRC-2022-0218-0177,NRC,NRC-2022-0218,"June 17, 2024 - Final Report - Advisory Committee on Medical Uses of Isotopes (ACMUI)",Supporting & Related Material,,2024-08-22T00:00:00Z,2024,8,,,2025-05-21T06:24:13Z,,0,0,090000648665e6f2
NRC-2022-0218-0053,NRC,NRC-2022-0218,STC-23-053 Notification of Proposed Rulemaking Fusion Energy Systems,Supporting & Related Material,,2023-07-24T00:00:00Z,2023,7,,,2025-05-21T06:33:38Z,,0,1,0900006485d2a16f
NRC-2022-0218-0045,NRC,NRC-2022-0218,Reporting Nuclear Medicine Injection Extravasations as Medical Events,Proposed Rule,,2023-07-18T00:00:00Z,2023,7,,,2025-05-21T06:33:43Z,2023-15130,0,0,0900006485cd23b6
NRC-2022-0218-0043,NRC,NRC-2022-0218,STC-23-033  Comment Extension Request from OAS Board,Supporting & Related Material,,2023-07-13T00:00:00Z,2023,7,,,2025-05-21T06:33:51Z,,0,0,0900006485ca04ae
NRC-2022-0218-0033,NRC,NRC-2022-0218,May 24 Extravasation Public Meeting Summary,Supporting & Related Material,,2023-06-29T00:00:00Z,2023,6,,,2025-05-21T06:34:10Z,,0,0,0900006485c1b265
NRC-2022-0218-0032,NRC,NRC-2022-0218,May 24 Extravasation Public Meeting Transcript,Supporting & Related Material,,2023-06-29T00:00:00Z,2023,6,,,2025-05-21T06:34:10Z,,0,0,0900006485c1b261
NRC-2022-0218-0009,NRC,NRC-2022-0218,Reporting Nuclear Medicine Injection Extravasations as Medical Events; Correction,Proposed Rule,,2023-04-25T00:00:00Z,2023,4,2023-04-25T00:00:00Z,,2025-05-21T06:35:07Z,2023-08685,0,0,09000064859844f2
NRC-2022-0218-0005,NRC,NRC-2022-0218,Preliminary Proposed Rule Language,Supporting & Related Material,,2023-04-20T00:00:00Z,2023,4,,,2025-05-21T06:35:17Z,,0,0,090000648596a26d
NRC-2022-0218-0004,NRC,NRC-2022-0218,Reporting Nuclear Medicine Injection Extravasations as Medical Events,Proposed Rule,,2023-04-19T00:00:00Z,2023,4,2023-04-19T00:00:00Z,2023-09-02T03:59:59Z,2025-05-21T06:35:17Z,2023-08238,0,0,090000648595e557
NRC-2022-0218-0003,NRC,NRC-2022-0218,"Mary Ajango, Spokesperson, Young Survival Coalition, Patients for Safer Nuclear Medicine Coalition Spokesperson, Letter re: NRC’s decision about extravasations",Supporting & Related Material,,2023-03-21T00:00:00Z,2023,3,,,2025-05-21T06:35:43Z,,0,1,0900006485815e65
NRC-2022-0218-0002,NRC,NRC-2022-0218,"March 11, 2024 - 12.	LTR-23-0081 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request Follow-up",Supporting & Related Material,,2023-03-21T00:00:00Z,2023,3,,,2025-05-21T06:35:43Z,,0,1,0900006485815e66
NRC-2022-0218-0001,NRC,NRC-2022-0218,Reporting Nuclear Medicine Injection Extravasations as Medical Events,Proposed Rule,,2022-12-30T00:00:00Z,2022,12,,,2025-05-21T06:36:17Z,2022-28356,0,0,0900006485568e61